Correlation Between Sihuan Pharmaceutical and Procaps Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sihuan Pharmaceutical and Procaps Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sihuan Pharmaceutical and Procaps Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sihuan Pharmaceutical Holdings and Procaps Group SA, you can compare the effects of market volatilities on Sihuan Pharmaceutical and Procaps Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sihuan Pharmaceutical with a short position of Procaps Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sihuan Pharmaceutical and Procaps Group.

Diversification Opportunities for Sihuan Pharmaceutical and Procaps Group

-0.2
  Correlation Coefficient

Good diversification

The 3 months correlation between Sihuan and Procaps is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Sihuan Pharmaceutical Holdings and Procaps Group SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Procaps Group SA and Sihuan Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sihuan Pharmaceutical Holdings are associated (or correlated) with Procaps Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Procaps Group SA has no effect on the direction of Sihuan Pharmaceutical i.e., Sihuan Pharmaceutical and Procaps Group go up and down completely randomly.

Pair Corralation between Sihuan Pharmaceutical and Procaps Group

Assuming the 90 days horizon Sihuan Pharmaceutical Holdings is expected to generate 1.4 times more return on investment than Procaps Group. However, Sihuan Pharmaceutical is 1.4 times more volatile than Procaps Group SA. It trades about 0.05 of its potential returns per unit of risk. Procaps Group SA is currently generating about -0.03 per unit of risk. If you would invest  8.50  in Sihuan Pharmaceutical Holdings on August 24, 2024 and sell it today you would earn a total of  1.00  from holding Sihuan Pharmaceutical Holdings or generate 11.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy92.34%
ValuesDaily Returns

Sihuan Pharmaceutical Holdings  vs.  Procaps Group SA

 Performance 
       Timeline  
Sihuan Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Good
Over the last 90 days Sihuan Pharmaceutical Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly weak technical indicators, Sihuan Pharmaceutical reported solid returns over the last few months and may actually be approaching a breakup point.
Procaps Group SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Procaps Group SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Sihuan Pharmaceutical and Procaps Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sihuan Pharmaceutical and Procaps Group

The main advantage of trading using opposite Sihuan Pharmaceutical and Procaps Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sihuan Pharmaceutical position performs unexpectedly, Procaps Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Procaps Group will offset losses from the drop in Procaps Group's long position.
The idea behind Sihuan Pharmaceutical Holdings and Procaps Group SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
CEOs Directory
Screen CEOs from public companies around the world